Predictors for significant changes in serum sulfated glycosaminoglycans at COPD exacerbations

E. Papakonstantinou (Basel/Thessaloniki, Switzerland), F. Baty (St. Gallen, Switzerland), M. Roth (Basel, Switzerland), M. Tamm (Basel, Switzerland), D. Stolz (Basel, Switzerland)

Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Session: Cellular responses and cell therapy in lung injury and repair
Session type: Poster Discussion
Number: 3850
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Papakonstantinou (Basel/Thessaloniki, Switzerland), F. Baty (St. Gallen, Switzerland), M. Roth (Basel, Switzerland), M. Tamm (Basel, Switzerland), D. Stolz (Basel, Switzerland). Predictors for significant changes in serum sulfated glycosaminoglycans at COPD exacerbations. 3850

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Serum heparan sulfate levels predict the etiology of acute exacerbations in COPD
Source: Virtual Congress 2021 – Respiratory infections and bronchiectasis outcomes
Year: 2021



Serum hyaluronidase-1 is increased in COPD exacerbations and is associated with COPD severity and outcomes
Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Year: 2018



Does serum uric acid levels predict in-hospital mortality in severe COPD exacerbations?
Source: International Congress 2015 – COPD: interesting notes
Year: 2015

Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013

Comparison of serum osteopontin levels in patients with exacerbations and stable chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Year: 2012

Serum periostin in patients hospitalized for COPD exacerbations
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015


Increased plasma fibrinogen could predict frequent exacerbations in asthma
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020


Extracellular matrix glycosaminoglycans can predict severity and outcome in COPD
Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium
Year: 2018

Increased serum endotoxin levels as biomarker in acute exacerbations of COPD.
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018

Serum SP-A and SP-D levels in patients admitted to the hospital with acute COPD exacerbation
Source: International Congress 2016 – Inflammatory biomarkers in airway diseases
Year: 2016


The relationhip between serum levels of Surfactant protein D in COPD exacerbation severity and mortality
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018

Acute exacerbations in COPD patients are associated with increased levels of hyaluronic acid and heparan sulfate in BAL
Source: International Congress 2014 – Translational studies in COPD
Year: 2014

Low level of serum free triiodothyronine can be a predictor of long-term mortality after COPD exacerbations
Source: Virtual Congress 2020 – Investigations of COPD
Year: 2020


Assessment of serum uric acid in COPD exacerbations
Source: International Congress 2017 – Markers of COPD progression
Year: 2017

Inflammatory serum profiles are consistent across independent exacerbations in COPD patients with a history of frequent exacerbations
Source: International Congress 2015 – COPD: interesting notes
Year: 2015


Collagen degradation profile in serum of patients with COPD or IPF
Source: Annual Congress 2012 - Monitoring of airway diseases: far from the airways
Year: 2012



The assesment of serum TNFα levels in COPD acute exacerbation and the effects of inhaler steroids on clinical and inflammatory determinants
Source: Eur Respir J 2002; 20: Suppl. 38, 312s
Year: 2002

Serum angiopoietin-2 levels in stable and exacerbated chronic obstructive pulmonary disease
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015


Predictors of exacerbations of COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 284s
Year: 2005

Changes in the induced sputum proteome during COPD exacerbations
Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases
Year: 2020